Gillian C. Ivers-Read
2014
In 2014, Gillian C. Ivers-Read earned a total compensation of $3.8M as EVP of Technical Operations and Chief Regulatory Officer at Clovis Oncology, a 134% increase compared to previous year.
Compensation breakdown
| Bonus | $180,000 |
|---|---|
| Option Awards | $3,222,177 |
| Salary | $395,217 |
| Other | $26,093 |
| Total | $3,823,487 |
Ivers-Read received $3.2M in option awards, accounting for 84% of the total pay in 2014.
Ivers-Read also received $180K in bonus, $395.2K in salary and $26.1K in other compensation.
Rankings
In 2014, Gillian C. Ivers-Read's compensation ranked 2,245th out of 13,032 executives tracked by ExecPay. In other words, Ivers-Read earned more than 82.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,245 out of 13,032 | 83rd |
Division Manufacturing | 802 out of 4,965 | 84th |
Major group Chemicals And Allied Products | 253 out of 1,690 | 85th |
Industry group Drugs | 196 out of 1,369 | 86th |
Industry Pharmaceutical Preparations | 161 out of 1,042 | 85th |
Source: SEC filing on April 26, 2017.
Ivers-Read's colleagues
We found four more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2014.
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019